MedPath

Han Wha Pharma Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus

Phase 2
Conditions
Diabetic Complication
Interventions
First Posted Date
2013-04-19
Last Posted Date
2016-08-17
Lead Sponsor
Han Wha Pharma Co., Ltd.
Target Recruit Count
136
Registration Number
NCT01836172
Locations
🇰🇷

Internal medicine, Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath